Is COLL A Good Stock To Buy Now?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 817 13F filings...
Collegium Pharmaceutical Inc (COLL)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 17,500,000 | $173,250 | 1.85% | ||
| 2. | Perceptive Advisors Joseph Edelman | 2,058,068 | $41,223 | 0.44% | |
| 3. | Camber Capital Management Stephen Dubois | 2,000,000 | $40,060 | 1.4% | |
| 4. | Rubric Capital Management David Rosen | 1,926,283 | $38,583 | 2.83% | |
| 5. | 35,995,000 | $34,967 | +11% | 1.33% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.18 | 10,000 | Officer | 110,227 | 2017-05-12 | Filing | |
| $10.59 | 2,375 | Director | 2,375 | 2016-08-12 | Filing | |
| $12.00 | 3,930 | Large Shareholder | 65,270 | 2015-05-12 | Filing | |
| $12.00 | 196,070 | Large Shareholder | 3,256,572 | 2015-05-12 | Filing | |
| $12.00 | 150,000 | Large Shareholder, Director | 1,887,332 | 2015-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.30 | 9,809 | Officer, Director | 278,307 | 2021-03-01 | Filing | |
| $22.56 | 54,959 | Officer, Director | 288,116 | 2021-03-01 | Filing | |
| $23.36 | 6,011 | Officer | 148,753 | 2021-03-01 | Filing | |
| $27.00 | 1,400 | Officer | 154,764 | 2018-05-10 | Filing | |
| $23.00 | 1,449 | Officer | 156,164 | 2018-01-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 30,434 | $609,594 | 0% | |
| 2. | 7,027 | $140,751 | 0% | |
| 3. | 5,087,509 | $101,903 | 0.04% | |
| 4. | 4,944 | $99,000 | 0.01% | |
| 5. | 2,838,217 | $56,850 | 0% |
News See All
Collegium Pharmaceutical Inc (COLL): Hedge Funds Taking Some Chips Off The Table
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). We reversed our stance on...
Did Hedge Funds Make The Right Call On Collegium Pharmaceutical Inc (COLL) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets...
Hedge Funds Keep Buying Collegium Pharmaceutical Inc (COLL)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings...
These Hedge Funds Cashed Out Of Collegium Pharmaceutical Inc (COLL) Too Early
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and...
Were Hedge Funds Right About Souring On Collegium Pharmaceutical (COLL)?
Legendary investors such as Jeffrey Talpins and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses...
Hedge Funds Have Never Been This Bullish On Collegium Pharmaceutical Inc (COLL)
How do we determine whether Collegium Pharmaceutical Inc (NASDAQ:COLL) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who...
Were Hedge Funds Right About Dumping Collegium Pharmaceutical Inc (COLL) ?
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period. The data we've gathered as a result gives...
Do Hedge Funds Love Collegium Pharmaceutical Inc (COLL)?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge...
Collegium Pharmaceutical, Inc. (NASDAQ:COLL): Are Hedge Funds Right About This Stock?
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity positions as of September 30....
Billionaire Hedge Funds
